Evidence map›Paper›PMID 32396284›Full record

ArticleCancer medicine2020

The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.

Jiahuai Wen, Feng Ye, Fengfeng Xie, Dan Liu, LeZhen Huang, Chen Fang, Shaowen Zhong, Liping Ren

Open access · goldAbstract readComparative Study
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Breast cancer liver metastasis: time to resection and criteria.Hepatobiliary surgery and nutrition · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiahuai WenDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.ORCID 0000-0001-7326-5980
Feng YeDepartment of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Fengfeng XieDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Dan LiuDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
LeZhen HuangDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Chen FangDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Shaowen ZhongDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Liping RenDepartment of Breast Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China.
Guangdong Provincial Hospital of Traditional Chinese Medicine · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCombined with systemic therapy, the surgical intervention for breast cancer liver metastases (BCLM) is increasingly accepted but lacks convincing evidence. The aim of this study was to evaluate the disease control efficacy of hepatic surgery in isolated BCLM patients.

methodsBetween 2012 and 2017, metastatic breast cancer patients with isolated liver metastasis and regular follow-up were identified. Cohort design was conducted to compare the progression-free survival (PFS) between the surgical and nonsurgical BCLM patients. Univariate analysis and multivariate Cox regression survival analyses were performed to identify significant prognostic factors.

resultIn all, 148 isolated BCLM patients were enrolled and 95 participants received hepatic surgery for metastatic lesions. With median follow-up of 36.47 months, there was no significant difference between hepatic surgical group and nonsurgical group for PFS (median PFS: 11.17 months vs 10.10 m, P = .092). Based on the multivariate analysis, the disease-free interval (DFI) was an independent prognostic factor for isolated BCLM patients. Among the surgical group, BCLM patients who had ideal response after first salvage systemic treatment experienced the best long-term survival (median PFS: 14.20 months).

conclusionFor isolated BCLM patients with ideal response in first-line medical treatment, surgical intervention (hepatectomy, radiofrequency ablation) combining with systemic treatment could bring improved progression-free survival compared to sole systemic treatment, indicating that hepatic surgery may be considered as a therapeutic choice for selected isolated BCLM patients in clinical practice.

Indexed as

AdultAntineoplastic AgentsBreast NeoplasmsCase-Control StudiesDisease-Free SurvivalFemaleHepatectomyHumansLiver NeoplasmsMiddle AgedProgression-Free SurvivalRadiofrequency AblationRegression AnalysisRetrospective StudiesSalvage TherapyAntineoplastic Agentsbreast cancerliver metastasissurgical intervention

Identifiers

PMID32396284
PMCPMC7333858
OpenAlexW3025711401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.